Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Bristol-Myers Squibb Company et al.
Current Parent Company: Bristol-Myers Squibb
Penalty: $458,006,000
Year: 2024
Date: May 21, 2024
Offense Group: safety-related offenses
Primary Offense: product safety violation
Secondary Offense: drug or medical equipment safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Bristol-Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi agreed to pay over $916 million for unfair and deceptive practices for failing to disclose the efficacy and safety profile of the drug Plavix. The announcement did not indicate how much each company would pay. Here we assume Bristol-Myers and Sanofi each paid half of the total.
Level of Government: state
Action Type: agency action
Agency: Hawaii Attorney General
Civil or Criminal Case: civil
Facility State: Hawaii
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.